Venumadhav R. Kotla
Expertise in
40
conditions

Dr. Venumadhav R. Kotla

Hematology Oncology
725 Jesse Jewell Parkway Southeast, 
Gainesville, GA 
Accepting New Patients
Offers Telehealth
Expertise in
40
conditions
725 Jesse Jewell Parkway Southeast, 
Gainesville, GA 

Overview

Venumadhav Kotla is a Hematologist Oncology provider practicing medicine in Gainesville, Georgia.

Dr. Kotla is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, B-Cell Lymphoma, Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.

Dr. Kotla is board certified in American Board Of Internal Medicine, Medical Oncology - 2009. He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 4 clinical trials. Dr. Kotla is currently accepting new patients.

Specialties

Hematology Oncology

Licenses

Internal Medicine in DE

Board Certifications

American Board Of Internal Medicine, Medical Oncology - 2009

Fellowships

Albert Einstein College of Medicine, Hematology & Oncology, 2008

Hospital Affiliations

Northeast Georgia Medical Center, Inc
Stephens County Hospital
Northeast Georgia Medical Center Habersham
University Health System, Inc

Languages Spoken

English
Hindi
Spanish
Telugu

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

The Longstreet Clinic, PC - Cancer Center
725 Jesse Jewell Parkway Southeast, Gainesville, GA 30501

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Molecular Analysis for Therapy Choice (MATCH)
Molecular Analysis for Therapy Choice (MATCH)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Drug, Other, Biological
Study Drugs: Adavosertib, Afatinib, Binimetinib, Capivasertib, Copanlisib, Crizotinib, Dabrafenib, Dasatinib, Defactinib, Erdafitinib, FGFR Inhibitor AZD4547, Ipatasertib, Larotrectinib, Nivolumab, Osimertinib, Palbociclib, Pertuzumab, PI3K-Beta Inhibitor GSK2636771, Sapanisertib, Sunitinib, Taselisib, Trametinib, Trastuzumab, Ulixertinib, Vismodegib
Study Phase: Phase 2
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Phase III Randomized, Placebo-Controlled Clinical Trial Evaluating the Use of Adjuvant Endocrine Therapy +/- One Year of Everolimus in Patients With High-Risk, Hormone Receptor-Positive and HER2/Neu Negative Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 10, 2026
Intervention Type: Drug, Other
Study Drugs: Anastrozole, Everolimus, Exemestane, Goserelin Acetate, Letrozole, Leuprolide Acetate, Tamoxifen Citrate
Study Phase: Phase 3
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Randomized Phase III Trial of Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Carfilzomib, Lenalidomide, and Dexamethasone (CRd) Followed by Limited or Indefinite Duration Lenalidomide Maintenance in Patients With Newly Diagnosed Symptomatic Multiple Myeloma (ENDURANCE)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Other, Drug
Study Drugs: Bortezomib, Carfilzomib, Dexamethasone, Lenalidomide
Study Phase: Phase 3
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Phase III Comparison of Thoracic Radiotherapy Regimens in Patients With Limited Small Cell Lung Cancer Also Receiving Cisplatin and Etoposide
Enrollment Status: Unknown
Publish Date: June 12, 2023
Intervention Type: Drug, Radiation
Study Drugs: Cisplatin, Etoposide, Carboplatin
Study Phase: Phase 3
View 3 Less Clinical Trials

2 Total Publications

Cirrhosis With Splenomegaly and Pancytopenia Complicating a Concurrent Diagnosis of Acute Lymphoblastic Leukemia.
Cirrhosis With Splenomegaly and Pancytopenia Complicating a Concurrent Diagnosis of Acute Lymphoblastic Leukemia.
Journal: Cureus
Published: November 04, 2022
Similar Doctors
Expertise in
26
conditions
Dr. Jonathon B. Cohen
Hematology Oncology
Expertise in
26
conditions
Dr. Jonathon B. Cohen
Hematology Oncology
Referral may be required
Before you request

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (46.7 miles away)
404-778-1900
Languages Spoken:
English, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Jonathon Cohen is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Cohen is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Vitrectomy. Dr. Cohen is board certified in American Board Of Internal Medicine, 2014. Dr. Cohen is currently accepting new patients.

Expertise in
21
conditions
Dr. Kristie A. Blum
Hematology Oncology
Expertise in
21
conditions
Dr. Kristie A. Blum
Hematology Oncology
Referral may be required
Before you request

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (46.7 miles away)
404-778-1900
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kristie Blum is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Blum is highly rated in 21 conditions, according to our data. Her clinical expertise encompasses Mantle Cell Lymphoma (MCL), Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Blum is board certified in American Board Of Internal Medicine, 2004. Dr. Blum is currently accepting new patients.

Expertise in
26
conditions
Dr. Edmund K. Waller
Hematology Oncology
Expertise in
26
conditions
Dr. Edmund K. Waller
Hematology Oncology
Referral may be required
Before you request

Emory Winship Cancer Institute

1365 Clifton Road Northeast, BldgC, 
Atlanta, GA 
 (46.7 miles away)
404-778-0519
Languages Spoken:
English, Italian, Mandarin, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Edmund Waller is a Hematologist Oncology provider practicing medicine in Atlanta, Georgia. Dr. Waller is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Transplant. Dr. Waller is board certified in American Board Of Internal Medicine, 1991. Dr. Waller is currently accepting new patients.

Frequently Asked Questions about Dr. Venumadhav R. Kotla

How do I make an appointment with Dr. Venumadhav R. Kotla?

You can book an appointment with Dr. Venumadhav R. Kotla by calling their office at 770-297-5700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Venumadhav R. Kotla a top-rated expert for Paget Disease of the Breast?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Venumadhav R. Kotla is classified as an Distinguished expert for Paget Disease of the Breast, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Venumadhav R. Kotla specialize in?

While Dr. Venumadhav R. Kotla is a Hematology Oncology, they have specific expertise in Paget Disease of the Breast, B-Cell Lymphoma, and Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Venumadhav R. Kotla participate in research or clinical trials?

Yes. Dr. Venumadhav R. Kotla has published 2 articles and abstracts on conditions like Paget Disease of the Breast. You can view a list of Dr. Venumadhav R. Kotla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Venumadhav R. Kotla accept my insurance?

Dr. Venumadhav R. Kotla accepts most major insurance plans, including Aetna and Alliant Health. We recommend calling the office directly at 770-297-5700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kotla's expertise for a condition
ConditionClose
    View All 37 Advanced Conditions
    View All 96 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile